These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients. Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli S, Turgan C. Artif Organs; 2009 Oct 18; 33(10):844-54. PubMed ID: 19681840 [Abstract] [Full Text] [Related]
9. Role of plaque calcification regulators osteoprotegerin and matrix Gla-proteins in stable angina and acute myocardial infarction. Margonato A, Gorla R, Macchi A, Buzzetti F, Franzoni I, Pedrigi MC, Rosa I, Sirtori M, Villa I, Rubinacci A. J Cardiovasc Med (Hagerstown); 2015 Mar 18; 16(3):156-62. PubMed ID: 24566391 [Abstract] [Full Text] [Related]
10. Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. Mesquita M, Demulder A, Wolff F, Mélot C, Damry N, Dratwa M, Bergmann P. Transplant Proc; 2010 Nov 18; 42(9):3444-9. PubMed ID: 21094794 [Abstract] [Full Text] [Related]
11. Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index. Hermans MM, Vermeer C, Kooman JP, Brandenburg V, Ketteler M, Gladziwa U, Rensma PL, Leunissen KM, Schurgers LJ. Blood Purif; 2007 Nov 18; 25(5-6):395-401. PubMed ID: 17890861 [Abstract] [Full Text] [Related]
16. Correlation of serum Klotho, fetuin-A, and MGP levels with coronary artery calcification in maintenance hemodialysis patients. Wang D, Chu X, Cao J, Peng Y. Clinics (Sao Paulo); 2024 Nov 18; 79():100417. PubMed ID: 39089098 [Abstract] [Full Text] [Related]
17. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Morena M, Dupuy AM, Jaussent I, Vernhet H, Gahide G, Klouche K, Bargnoux AS, Delcourt C, Canaud B, Cristol JP. Nephrol Dial Transplant; 2009 Nov 18; 24(11):3389-97. PubMed ID: 19574342 [Abstract] [Full Text] [Related]
19. Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings? Hosbond SE, Diederichsen AC, Saaby L, Rasmussen LM, Lambrechtsen J, Munkholm H, Sand NP, Gerke O, Poulsen TS, Mickley H. Atherosclerosis; 2014 Oct 18; 236(2):230-6. PubMed ID: 25104079 [Abstract] [Full Text] [Related]
20. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography. Ahmed S, Sobh R. Endocr Metab Immune Disord Drug Targets; 2019 Oct 18; 19(6):845-851. PubMed ID: 30747085 [Abstract] [Full Text] [Related] Page: [Next] [New Search]